1. Home
  2. SLDB vs ADAM Comparison

SLDB vs ADAM Comparison

Compare SLDB & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

SELL

Current Price

$6.43

Market Cap

623.0M

Sector

Health Care

ML Signal

SELL

Logo Adamas Trust Inc.

ADAM

Adamas Trust Inc.

HOLD

Current Price

$4.86

Market Cap

702.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLDB
ADAM
Founded
2013
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
623.0M
702.0M
IPO Year
2017
2003

Fundamental Metrics

Financial Performance
Metric
SLDB
ADAM
Price
$6.43
$4.86
Analyst Decision
Strong Buy
Hold
Analyst Count
15
7
Target Price
★ $18.71
$11.17
AVG Volume (30 Days)
1.2M
★ 1.6M
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
★ 25.26%
EPS Growth
34.97
★ 196.49
EPS
N/A
★ N/A
Revenue
★ $8,094,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.09
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.65
$4.60
52 Week High
$11.45
$10.36

Technical Indicators

Market Signals
Indicator
SLDB
ADAM
Relative Strength Index (RSI) 46.83 19.95
Support Level $6.25 N/A
Resistance Level $6.58 $9.36
Average True Range (ATR) 0.50 0.31
MACD 0.02 -0.06
Stochastic Oscillator 30.12 8.74

Price Performance

Historical Comparison
SLDB
ADAM

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

Share on Social Networks: